Chest Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text Free
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wenzel, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wenzel, S.
(Chest. 2003;123:405S-410S.)
© 2003 American College of Chest Physicians

Severe/Fatal Asthma*

Sally Wenzel, MD, FCCP

* From the National Jewish Medical and Research Center, Denver, CO.

Correspondence to: Sally Wenzel, MD, FCCP, National Jewish Medical and Research Center, 1400 Jackson St, Denver, CO 80206; e-mail: wenzels{at}njc.org

Severe asthma is poorly understood clinically, physiologically, and pathologically. While milder forms of asthma are generally easily treated, more severe forms often remain refractory to the best current medical care. Although some patients with severe asthma have had severe disease for most of their lives, there appears to be a second group that develops severe disease in adulthood. Additionally, it is not clear which genetic and environmental elements may be the most important in the development of severe disease. Physiologically, these patients often have airtrapping and may have loss of elastic recoil, as well. The pathology demonstrates a heterogeneity of findings, including continued eosinophilic inflammation, structural changes, distal disease, and, in at least one third of patients, a different pathology. Treatment remains problematic and likely will remain so until a better understanding of this disease develops.

Key Words: asthma • inflammation • phenotypes • physiology • remodeling • treatment




This article has been cited by other articles:


Home page
ChestHome page
M. Tsoumakidou, E. Papadopouli, N. Tzanakis, and N. M. Siafakas
Airway Inflammation and Cellular Stress in Noneosinophilic Atopic Asthma
Chest, May 1, 2006; 129(5): 1194 - 1202.
[Abstract] [Full Text] [PDF]


Home page
Proc Am Thorac SocHome page
R. A. Pauwels
Similarities and Differences in Asthma and Chronic Obstructive Pulmonary Disease Exacerbations
Proceedings of the ATS, April 1, 2004; 1(2): 73 - 76.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
J. M. Drazen
Asthma and the Human Genome Project: Summary of the 45th Annual Thomas L. Petty Aspen Lung Conference
Chest, March 1, 2003; 123(2007): 447S - 449S.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by the American College of Chest Physicians.